« Previous
Next »
Journal of Cardiothoracic and Vascular Anesthesia
Volume 24, Issue 2
, Pages 250-256
, April 2010
Validity of an Arterial Pressure Waveform Analysis Device: Does the Puncture Site Play a Role in the Agreement With Intermittent Pulmonary Artery Catheter Thermodilution Measurements?
References
- The effectiveness of right heart catheterization in the initial care of critically ill patients (SUPPORT Investigators). JAMA. 1996;276:889–897
- . Death by pulmonary artery flow-directed catheter (Time for a moratorium?). Chest. 1987;92:727–731
- A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348:5–14
- Continuous cardiac output measurement: arterial pressure analysis versus thermodilution technique during cardiac surgery with cardiopulmonary bypass. Anaesthesia. 2007;62:979–983
- Uncalibrated arterial pulse contour analysis versus continuous thermodilution technique: Effects of alterations in arterial waveform. J Cardiothorac Vasc Anesth. 2007;21:636–643
- Comparison of FloTrac cardiac output monitoring system in patients undergoing coronary artery bypass grafting with pulmonary artery cardiac output measurements. Eur J Anaesthesiol. 2007;24:832–839
- Semi-invasive monitoring of cardiac output by a new device using arterial pressure waveform analysis: A comparison with intermittent pulmonary artery thermodilution in patients undergoing cardiac surgery. Br J Anaesth. 2007;98:176–182
- Evaluation of a new arterial pressure-based cardiac output device requiring no external calibration. BMC Anesthesiol. 2007;7:9
- Clinical evaluation of the FloTrac/Vigileo system and two established continuous cardiac output monitoring devices in patients undergoing cardiac surgery. Br J Anaesth. 2007;99:329–336
- Cardiac output derived from arterial pressure waveform analysis in patients undergoing cardiac surgery: Validity of a second generation device. Anesth Analg. 2008;106:867–872
- . A meta-analysis of studies using bias and precision statistics to compare cardiac output measurement techniques. J Clin Monit Comput. 1999;15:85–91
- . Cardiac output determination from the arterial pressure wave: Clinical testing of a novel algorithm that does not require calibration. J Cardiothorac Vasc Anesth. 2007;21:3–7
- Cardiac output measurement by arterial waveform analysis in cardiac surgery—A comparison of measurements derived from waveforms of the radial artery versus the ascending aorta. J Int Med Res. 2008;36:414–419
- Uncalibrated pulse contour-derived stroke volume variation predicts fluid responsiveness in mechanically ventilated patients undergoing liver transplantation. Br J Anaesth. 2008;101:761–768
- Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery. Br J Anaesth. 2009;102:47–54
- Cardiac output monitoring: Comparison of a new arterial pressure waveform analysis to the bolus thermodilution technique in patients undergoing off-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2008;22:394–399
- Performance of a minimally invasive uncalibrated cardiac output monitoring system (Flotrac/Vigileo) in haemodynamically unstable patients. Br J Anaesth. 2008;100:451–456
Supported by departmental funds and Edwards Lifescience, LLC (Irvine, CA) who delivered the Vigileo monitors and the FloTrac transducers.
The impact of the arterial puncture site is not negligible, when the FloTrac/Vigileo system is used to measure hemodynamic data. Compared with the thermodilution bolus technique using the pulmonary artery catheter, large differences were observed. Therefore, the use of this device should be questioned in cardiac surgery.
In the past 5 years, D.R.S. has received honoraria or travel support for consulting or lecturing from the following companies: Abbott AG, Baar, Switzerland; Alliance Pharmaceutical Corp, San Diego, CA; AstraZeneca AG, Zug, Switzerland; Bayer (Schweiz) AG, Zürich, Switzerland; B. Braun Melsungen AG, Melsungen, Germany; CSL Behring GmbH, Hattersheim am Main, Germany; Fresenius SE, Bad Homburg v.d.H., Germany; Galenica AG, Bern, Switzerland (including Vifor SA, Villars-sur-Glâne, Switzerland); GlaxoSmithKline GmbH & Co KG, Hamburg, Germany; Janssen-Cilag AG, Baar, Switzerland; Novo Nordisk A/S, Bagsvärd, Denmark; Octapharma AG, Lachen, Switzerland; Organon AG, Pfäffikon/SZ, Switzerland; and Roche Pharma (Schweiz) AG, Reinach, Switzerland.
PII: S1053-0770(09)00211-0
doi: 10.1053/j.jvca.2009.05.029
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Cardiothoracic and Vascular Anesthesia
Volume 24, Issue 2
, Pages 250-256
, April 2010
